Pfizer Unusual Options Activity For October 25
Portfolio Pulse from Benzinga Insights
A significant amount of unusual options activity has been observed for Pfizer (NYSE:PFE), with a majority of investors taking a bullish stance. The targeted price range for Pfizer over the last 3 months has been $27.5 to $35.0. The current price of PFE is $30.45, up 0.08%. Analysts from Truist Securities, JP Morgan, Wells Fargo, and Citigroup maintain their ratings on Pfizer, while Cantor Fitzgerald downgraded its action to Overweight with a price target of $75.
October 25, 2023 | 3:16 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pfizer has seen unusual options activity, with a majority of investors bullish. The stock is currently priced at $30.45, up 0.08%. Analyst ratings remain mostly unchanged, except for Cantor Fitzgerald which upgraded to Overweight.
The bullish stance of majority investors and the upgrade from Cantor Fitzgerald could potentially drive the stock price up in the short term. However, the risk associated with options trading and the upcoming earnings release could introduce volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100